In prostate cancer, HERV-E (and/or ERV3) env genes was expressed only in prostate tumor cells that suggested as targets for immunotherapy for the disease (Wang-Johanning et al., 2003). This evidence concerns the gene ERV3-1 and Familial prostate cancer.